Journal of Cancer Therapy
Vol.4 No.2(2013), Paper ID 29920, 6
pages
DOI:10.4236/jct.2013.42074
Phase II Study of Irinotecan plus S-1 in Treatment of Advanced Gastric Cancer
Hideki Bou, Akira Tokunaga, Hideyuki Suzuki, Nobuo Murata, Yasuyuki Sugiyama, Naoto Fukuda, Masahiro Ishimaru, Hiroyuki Suzuki
Institute of Gastroenterology, Nippon Medical School Musashi Kosugi Hospital, Kawasaki, Japan
Institute of Gastroenterology, Nippon Medical School Musashi Kosugi Hospital, Kawasaki, Japan
Institute of Gastroenterology, Nippon Medical School Musashi Kosugi Hospital, Kawasaki, Japan
Department of Surgery, University Hospital of Mizonokuchi, Teikyo University School of Medicine, Kawasaki, Japan
Department of Surgery, University Hospital of Mizonokuchi, Teikyo University School of Medicine, Kawasaki, Japan
Department of Surgery, University Hospital of Mizonokuchi, Teikyo University School of Medicine, Kawasaki, Japan
Department of Surgery, Kanto Rosai Hospital, Kawasaki, Japan
Department of Surgery, Kanto Rosai Hospital, Kawasaki, Japan
Copyright © 2013 Hideki Bou, Akira Tokunaga, Hideyuki Suzuki, Nobuo Murata, Yasuyuki Sugiyama, Naoto Fukuda, Masahiro Ishimaru, Hiroyuki Suzuki et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
H. Bou, A. Tokunaga, H. Suzuki, N. Murata, Y. Sugiyama, N. Fukuda, M. Ishimaru and H. Suzuki, "Phase II Study of Irinotecan plus S-1 in Treatment of Advanced Gastric Cancer,"
Journal of Cancer Therapy, Vol. 4 No. 2, 2013, pp. 578-583. doi:
10.4236/jct.2013.42074.